Clinical Trials Directory

Trials / Unknown

UnknownNCT04457557

Local Anesthetic Concentration and Rebound Pain

Evaluation of the Effect of Local Anesthetic Concentration on Rebound Pain After Interscalene Block for Shoulder Surgery

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Ajou University School of Medicine · Academic / Other
Sex
All
Age
19 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The rebound pain after nerve block could interfere with patient's recovery and rehabilitation. It is not known how local anesthetic concentrations affect rebound pain. The aim of this study is evaluation of the effect of local anesthetic concentration on rebound pain after interscalene block for shoulder surgery.

Detailed description

Shoulder surgery is related to more than moderate pain after surgery. Interscalene nerve block could reduce the postoperative pain effectively. When the effect of nerve block ends, however, rebound pain could appear. The rebound pain could interfere with patient's recovery and rehabilitation. The mechanism of rebound pain is not well known. One of possible mechanism is that the pain stimulus that was blocked suddenly comes out, and it is perceived as more severe pain. The strength of the block may vary depending on the concentration of the local anesthetic. Therefore, the concentration of local anesthetics could affect rebound pain. The aim of this study is evaluation of the effect of local anesthetic concentration on rebound pain after interscalene block for shoulder surgery.

Conditions

Interventions

TypeNameDescription
OTHERReduced concentration of local anesthetic (ropivacaine)Reduced concentration of ropivacaine We usually use 0.5% ropivacaine in our facility. The intervention group used 0.15% ropivacaine 15 ml
OTHERUsual concentration of local anesthetic (ropivacaine)0.5% ropivacaine 15ml

Timeline

Start date
2020-07-10
Primary completion
2023-06-30
Completion
2023-07-31
First posted
2020-07-07
Last updated
2022-09-30

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04457557. Inclusion in this directory is not an endorsement.